Went public on 7/18/2000 at $15 per share
Filing Range: 4 mil. shares @ $12 to $14
Share Outstanding: 17.33 mil. shares
Underwriters: Chase H&Q/Bear, Stearns & Co./Dain Rauscher Wessels
Company Counsel: Kutak Rock
Manager Counsel: Milbank Tweed Hadley & McCloy LLP
Auditor: Deloitte & Touche LLP
Designs and manufactures a broad range of chromatography products, sample introduction and detection products, and on-line process monitoring systems, under the name CETAC Technologies. The company’s core biotechnology business includes principle technologies for DNA/RNA and protein analysis and separations.
Granite Ventures LLC
Number of Round Amt.
Round # Round Date Stage Investors ($ thousands)
1 03/24/1999 1 Early Stage 300.0
(Data in $ millions)
Total Revenues: $23.0
Net Income: -9.8